Bayer
NEWS
According to the second biennial 2019 Life Sciences Ideal Employer Report by BioSpace, the top three most important attributes cited by life sciences professionals around the world are the opportunity to do interesting and meaningful work, a competitive salary and health benefits.
Bayer, Brigham and Women’s Hospital and Massachusetts General Hospital have launched a joint laboratory to research new drugs to treat chronic lung diseases.
Savonix, a global leader in digital tests for cognitive health, and Bayer’s Consumer Health Division today announced a partnership agreement to work together to validate the effects of Bayer’s multivitamin supplement Berocca in the Malaysian market.
The two companies also inked a commercial licensing deal for Bayer to use One Drop’s platform in Bayer’s worldwide bio-digital efforts in oncology, cardiovascular disease and women’s health.
Biotech and pharma companies strengthen their leadership teams with new appointments.
Biopharma companies strengthen the C-suite and board of directors with these appointments.
Under the terms of the acquisition, Bayer is buying the rest of the company for $240 million up front with an additional $360 million in various development milestones. This will correspond with the company’s value of about $1 billion.
First major drug development agreement signed by Sensyne Health since IPO with potential for expansion
The U.S. Food and Drug Administration approved Bayer’s Nubeqa (darolutamide) for non-metastatic castration-resistant prostate cancer.
JOBS
IN THE PRESS